Previous Close | 0.09200 |
Open | 0.09200 |
Bid | 0.00000 x 0 |
Ask | 0.00000 x 0 |
Day's Range | 0.09000 - 0.09495 |
52 Week Range | 0.06000 - 0.25000 |
Volume | 267,089 |
Avg. Volume | 625,033 |
Market Cap | 72.93M |
Beta | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Categories: Yahoo FinanceGet free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Acura Pharmaceuticals, Inc., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc. and Albany Molecular Research, Inc. (MYL-US, ACUR-US, CBM-US, ACET-US, NKTR-US, PFE-US ... Read more (Read more...)